logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Expanding access to treatment for hepatitis C in resource-limited settings: Lessons from HIV/AIDS

Ford NP, Singh K, Cooke GS, Mills EJ, von Schoen-Angerer T,  et al.
2012-03-19 • Clinical Infectious Diseases
2012-03-19 • Clinical Infectious Diseases
Journal Article
|
Commentary

Viral hepatitis and the global burden of disease: a need to regroup

Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A,  et al.
2013-08-05 • Journal of Viral Hepatitis
2013-08-05 • Journal of Viral Hepatitis
Journal Article
|
Commentary

New opportunities in tuberculosis prevention: implications for people living with HIV

Gonzalez Fernandez L, Casas EDT, Singh SN, Churchyard GJ, Brigden G,  et al.
2020-01-01 • Journal of the International AIDS Society
2020-01-01 • Journal of the International AIDS Society
INTRODUCTION:
Tuberculosis (TB) is a leading cause of mortality among people living with HIV (PLHIV). An invigorated global END TB Strategy seeks to increase efforts in scaling up T...
Journal Article
|
Research

Chronic Hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis

Ford NP, Kirby C, Singh KR, Mills EJ, Cooke GS,  et al.
2012-02-03 • Bulletin of the World Health Organization
2012-02-03 • Bulletin of the World Health Organization
To assess the effectiveness of treatment for hepatitis C virus (HCV) infection in low- and middle-income countries and identify factors associated with successful outcomes.